A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...
FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7. The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury ...
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to ...
Beginning Friday night, FDA employees overseeing medical devices, food ingredients and other key areas received calls and emails notifying them that their recent terminations had been “rescinded ...
If you have a complaint about a product regulated by the U.S. Food and Drug Administration (FDA), the agency wants to hear about it. The FDA offers a number of ways to report a complaint.
Stay up to date on the latest rates and trends for certificates of deposit (CD). Top CD Rates Today, Dec. 9, 2024 - Take Your Pick of 5.50% Until August or 5% for One Year ...
The FDA's announcement comes months after drugmaker Novo Nordisk told the agency that all dosages of its semaglutide product had become fully available nationwide. The company said in a statement ...
The agency updates and modifies the alerts as needed. Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Click here to go to the FDA page with links to ...
Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration ...
PINYA XP Logo The trademark application covers the Company's unique ... The application has been assigned Serial Number 99046064 by the USPTO. While registration is not automatic or guaranteed, the ...
The FDA's regulations and guidance regarding blood donor eligibility and donation testing protect the health of both the donor and the blood product recipient. The FDA's blood safety efforts focus ...